JJ
Jeffrey Janus
Director

Jeffrey Janus insider trades: International Stem Cell (ISCO.OB) stock buys and sales

Director, International Stem Cell Last trade Dec 1, 2010 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2007
3
Companies
last trade 2010

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 1, 2010ISCO.OB↓ Sell10b5-1$52K
Nov 30, 2010ISCO.OB↓ Sell10b5-1$95K
Nov 26, 2010ISCO.OB↓ Sell10b5-1$9K
Nov 24, 2010ISCO.OB↓ Sell10b5-1$166K
Oct 27, 2010ISCO.OB↓ Sell10b5-1$178K
Apr 2, 2008ISCO↑ Buy$2K
Sep 5, 2007ICOS↑ Buy$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey Janus's insider trades

Jeffrey Janus is a director at International Stem Cell (ISCO.OB). Since Sep 5, 2007, Jeffrey has reported 2 open-market purchases worth $5K and 5 sales worth $501K on SEC Form 4. There have been no open-market trades in the last 12 months.

5 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ISCO.OB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.